Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes.
Lok BH, Setton J, Caria N, Romanyshyn J, Wolden SL, Zelefsky MJ, Park J, Rowan N, Sherman EJ, Fury MG, Ho A, Pfister DG, Wong RJ, Shah JP, Kraus DH, Zhang Z, Schupak KD, Gelblum DY, Rao SD, Lee NY. Lok BH, et al. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1851-7. doi: 10.1016/j.ijrobp.2011.03.029. Epub 2011 Jun 2. Int J Radiat Oncol Biol Phys. 2012. PMID: 21640497 Free PMC article.
Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer.
Koutcher L, Sherman E, Fury M, Wolden S, Zhang Z, Mo Q, Stewart L, Schupak K, Gelblum D, Wong R, Kraus D, Shah J, Zelefsky M, Pfister D, Lee N. Koutcher L, et al. Among authors: schupak k. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):915-22. doi: 10.1016/j.ijrobp.2010.07.008. Epub 2010 Oct 13. Int J Radiat Oncol Biol Phys. 2011. PMID: 20947269
Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma.
Fury MG, Xiao H, Sherman EJ, Baxi S, Smith-Marrone S, Schupak K, Gewanter R, Gelblum D, Haque S, Schoder H, Shah JP, Katabi N, Kurtzman R, Lipson B, Cox L, Lee NY, Pfister DG. Fury MG, et al. Among authors: schupak k. Head Neck. 2016 Apr;38 Suppl 1(Suppl 1):E566-70. doi: 10.1002/hed.24041. Epub 2015 Jul 6. Head Neck. 2016. PMID: 25784616 Free PMC article. Clinical Trial.
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience.
Setton J, Caria N, Romanyshyn J, Koutcher L, Wolden SL, Zelefsky MJ, Rowan N, Sherman EJ, Fury MG, Pfister DG, Wong RJ, Shah JP, Kraus DH, Shi W, Zhang Z, Schupak KD, Gelblum DY, Rao SD, Lee NY. Setton J, et al. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):291-8. doi: 10.1016/j.ijrobp.2010.10.041. Epub 2010 Dec 16. Int J Radiat Oncol Biol Phys. 2012. PMID: 21167652
Neck spasms: A late sequela of head and neck irradiation.
Gelblum DY, Thompson M, Wolden SL, Schupak KD, Berry SL, Lee N. Gelblum DY, et al. Among authors: schupak kd. Oral Oncol. 2016 Jun;57:e4-5. doi: 10.1016/j.oraloncology.2016.03.016. Epub 2016 Apr 22. Oral Oncol. 2016. PMID: 27117320 No abstract available.
40 results